Topics

The Myth of Drug Expiration Dates

By Nav Dhillon

|
February 16, 2023

There’s not necessarily anything scientific or magical about the dates printed on medications Those expiration dates stamped on everything from a gallon of milk to a bottle of acetaminophen don’t…
Luckbox Leans in with Mark Cuban

By James Melton

|
February 16, 2023

Cost Plus Drugs Company is selling prescription medications at dramatically low prices What would happen if drug pricing made sense to consumers? Mark Cuban Cost Plus Drug Company, which launched…
ADHD Meds? You May Have to Wait

By James Melton

|
February 16, 2023

A shortage began with Adderall and spread to Ritalin. A government crackdown made it worse. As 2023 began, the national Adderall shortage had spread to other drugs used to treat…
Betting on Biotech

By Garrett Baldwin

|
February 16, 2023

Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite buying, cash to value and cash flow Sick people need medicine no matter…
The First $100 Billion Drug

By Ed McKinley

|
February 16, 2023

An obesity medication is reportedly poised to shatter the record for pharmaceutical sales volume A prescription drug that combats obesity is expected to become the biggest-grossing pharmaceutical in history, ringing…
Off-label, But Lucrative

By Nav Dhillon

|
February 16, 2023

Big pharma profits when doctors prescribe a drug for a disorder other than the one that earned FDA approval. The practice ranges from evidence-based to highly egregious. One in five…
Competition Coming for AbbVie’s Blockbuster

By Andrew Prochnow

|
February 16, 2023

It’s among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats Worldwide sales of Humira have totaled $200 billion in the last 20 years—just about the biggest haul…
The Luckbox Roundtable

By James Melton

|
February 16, 2023

Mark Cuban, the nation’s newest retail drug impresario, joins our expert panel to weigh in on the state of American pharma. Here’s what our panelists say lies ahead. (Luckbox lightly…
What to Know About Earnings Season

By Sage Anderson

|
January 11, 2023

Expectations for quarterly earnings season—which ramps up on Jan. 13—are tempered at this time due to the backdrop of rising interest rates and a slowing global economy
2023: Expect A Trader’s Market

By Garrett Baldwin

|
January 3, 2023

Chaos will roil the economy this year, but the Federal Reserve is creating market opportunities for active investors Keeping active doesn’t just improve your health. It also bolsters financial well-being.…

Topics

Top 10 Markets Traded